BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 27921220)

  • 1. Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.
    Pérez-Santiago J; De Oliveira MF; Var SR; Day TRC; Woods SP; Gianella S; Mehta SR
    J Neurovirol; 2017 Apr; 23(2):283-289. PubMed ID: 27921220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.
    Pérez-Santiago J; Schrier RD; de Oliveira MF; Gianella S; Var SR; Day TR; Ramirez-Gaona M; Suben JD; Murrell B; Massanella M; Cherner M; Smith DM; Ellis RJ; Letendre SL; Mehta SR
    J Neurovirol; 2016 Apr; 22(2):191-200. PubMed ID: 26428514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study.
    Hoenigl M; de Oliveira MF; Pérez-Santiago J; Zhang Y; Morris S; McCutchan AJ; Finkelman M; Marcotte TD; Ellis RJ; Gianella S
    Medicine (Baltimore); 2016 Mar; 95(11):e3162. PubMed ID: 26986173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.
    Mehta SR; Pérez-Santiago J; Hulgan T; Day TR; Barnholtz-Sloan J; Gittleman H; Letendre S; Ellis R; Heaton R; Patton S; Suben JD; Franklin D; Rosario D; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur J; McCutchan A; Morgello S; Simpson D; Connor J; Grant I; Kallianpur A
    J Neuroinflammation; 2017 Mar; 14(1):72. PubMed ID: 28359324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.
    Mothapo KM; Ten Oever J; Koopmans P; Stelma FF; Burm S; Bajramovic J; Verbeek MM; Rikkert MGO; Netea MG; Koopman G; van der Ven AJ
    J Neurovirol; 2017 Apr; 23(2):250-259. PubMed ID: 27882497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
    Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
    Oliveira MF; Chaillon A; Nakazawa M; Vargas M; Letendre SL; Strain MC; Ellis RJ; Morris S; Little SJ; Smith DM; Gianella S
    PLoS Pathog; 2017 Jan; 13(1):e1006112. PubMed ID: 28046096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
    Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
    HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.
    Burdo TH; Weiffenbach A; Woods SP; Letendre S; Ellis RJ; Williams KC
    AIDS; 2013 Jun; 27(9):1387-95. PubMed ID: 23435298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
    Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
    BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
    Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
    J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).
    Schrier RD; Hong S; Crescini M; Ellis R; Pérez-Santiago J; Spina C; Letendre S;
    PLoS One; 2015; 10(2):e0116526. PubMed ID: 25719800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
    Premeaux TA; D'Antoni ML; Abdel-Mohsen M; Pillai SK; Kallianpur KJ; Nakamoto BK; Agsalda-Garcia M; Shiramizu B; Shikuma CM; Gisslén M; Price RW; Valcour V; Ndhlovu LC
    J Neurovirol; 2019 Apr; 25(2):150-161. PubMed ID: 30478799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.
    Thames AD; Briones MS; Magpantay LI; Martinez-Maza O; Singer EJ; Hinkin CH; Morgello S; Gelman BB; Moore DJ; Heizerling K; Levine AJ
    AIDS; 2015 Jul; 29(12):1483-91. PubMed ID: 26244388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.
    Spudich S; Robertson KR; Bosch RJ; Gandhi RT; Cyktor JC; Mar H; Macatangay BJ; Lalama CM; Rinaldo C; Collier AC; Godfrey C; Eron JJ; McMahon D; Jacobs JL; Koontz D; Hogg E; Vecchio A; Mellors JW
    J Clin Invest; 2019 Jul; 129(8):3339-3346. PubMed ID: 31305262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.
    Yuan L; Qiao L; Wei F; Yin J; Liu L; Ji Y; Smith D; Li N; Chen D
    J Neurovirol; 2013 Apr; 19(2):144-9. PubMed ID: 23389619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
    Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
    Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
    Højen JF; Rasmussen TA; Andersen KL; Winckelmann AA; Laursen RR; Gunst JD; Møller HJ; Fujita M; Østergaard L; Søgaard OS; Dinarello CA; Tolstrup M
    Mol Med; 2015 Apr; 21(1):337-45. PubMed ID: 25879630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.
    de Almeida SM; Rotta I; Jiang Y; Li X; Raboni SM; Ribeiro CE; Smith D; Potter M; Vaida F; Letendre S; Ellis RJ;
    J Neurovirol; 2016 Dec; 22(6):715-724. PubMed ID: 27400932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
    Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.